Related Experiment Videos

Prophylactic antibiotics and pancreatic necrosis

B Gloor1, O Schmidt, W Uhl

  • 1Department of Visceral and Transplantation Surgery, University of Bern, Inselspital, CH 3010, Bern, Switzerland.

Current Gastroenterology Reports
|March 29, 2001
PubMed

Insights

Early antibiotic use may benefit severe acute pancreatitis patients but risks resistant infections. Optimal antibiotic strategies remain unclear, and prophylactic antifungals are not currently supported by data.

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Critical Care Medicine

Background:

  • Severe acute pancreatitis (SAP) management involves addressing infection risks.
  • Antibiotic use in SAP is debated due to potential for resistance and fungal infections.
  • Current evidence on optimal antibiotic strategies for SAP is limited.

Purpose of the Study:

  • To evaluate the impact of early antibiotic treatment on SAP outcomes.
  • To assess the risks associated with widespread antibiotic use in SAP.
  • To determine the efficacy of prophylactic antifungal agents in SAP.

Main Methods:

  • Review of recent controlled clinical studies on antibiotic treatment in SAP.
  • Analysis of data regarding morbidity and mortality in SAP patients.
  • Evaluation of the incidence of fungal infections and multiresistant bacteria.

Main Results:

  • Controlled studies suggest early antibiotics may reduce late morbidity and mortality in SAP.
  • Widespread antibiotic use is associated with increased fungal infections and multiresistant bacteria.
  • Optimal antibiotic choice, duration, and administration routes are not yet established.

Conclusions:

  • Early antibiotic treatment may offer benefits in SAP, but requires careful consideration of risks.
  • The emergence of fungal infections and antibiotic resistance is a significant concern.
  • Prophylactic antifungal administration in SAP is not supported by current evidence.

Related Concept Videos